Saturday, 24th October 2009

Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians

Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Source: Archives of Internal Medicine

The evidence regarding the utility of hormonal blood tests in identifying and affecting therapeutic outcomes for treatable causes of ED was inconclusive. The evidence demonstrated clinical benefit associated with the use of PDE-5 inhibitors regardless of the cause (such as diabetes, depression, or prostate cancer) or baseline severity of ED. The magnitude of benefit increased with severity of ED. Higher doses of sildenafil and vardenafil were associated with a modestly greater magnitude of benefit with respect to erectile function; however, this was not true for tadalafil. Overall, PDE-5 inhibitors were relatively well tolerated and were associated with mild or moderate adverse events. The incidence of adverse events did not significantly differ among the various PDE-5 inhibitors. Evidence was insufficient to determine whether PDE-5 inhibitors are associated with an increased risk for NAION.

Category:

• Diseases and conditions (DocuTicker)
• Health and healthcare (DocuTicker)

Source:

• Archives of Internal Medicine

Views: 416

Please note: DocuTicker's editors collect citations for full-text PDF reports freely available on the web but we do not archive these reports. When you click a link to find and/or download the report, you are leaving the DocuTicker site. DocuTicker makes no representations regarding the ongoing availability of any report or any external resource. Links were accurate as of the date of posting.

FreePint

FreePint supports the value of information in the enterprise. Read more »

Latest FreePint Articles:

• Experiences in FreePint Engagement
  Thursday, 20th June 2013

  FreePint's Communities of Practice (CoP) offer a convenient and compelling way for FreePint Subscribers to share information openly with colleagues and to discuss their challenges and experiences around topics such as mobile deployment in the enterprise. Joining a CoP allows Subscribers to communicate with their peers around the world to discuss global issues in information management and strategy. Robin Neidorf introduces the new FreePint CoP: news aggregation.

• FreePint's SLA Recap
  Thursday, 20th June 2013

  As always at professional gatherings, SLA attendees took full advantage of the opportunity to share ideas, ask questions of one another, and learn about emerging areas of information work.

• Big Data In Action: Epilogue
  Wednesday, 19th June 2013

  The FreePint Series: Big Data in Action wrapped up with a global webinar. Victor Camlek reviews the highlights of the webinar, recent interviews with key big data experts Attunity, Connotate, Linguamatics and Opera Solutions, and offers a final view of the Series.

• ... more ...

All Family Articles »
Family Articles by Category »

A FreePint Subscription delivers articles and reports that support your organisation's information practice, content and strategy.

Start the conversation about a subscription by
completing our online form: "How can FreePint help?"

FreePint Testimonials

" FreePint has been an excellent resource to both myself and colleagues for furthering insight, bringing together snapshots of easily digestible ..."

Read more testimonials and supply yours »